In this ondemand webcast experts discuss the strategic management of relapsed and refractory chronic lymphocytic leukemia CLL During the discussion there will be an emphasis on the importance of personalized evidencebased sequencing of therapies to maximize treatment efficacy and improve patient outcomes
- Provider:Clinical Care Options
- Activity Link: https://clinicaloptions.com/CE-CME/hematology/sequencing-in-relapsed-refractory-cll/30981-64195
- Start Date: 2024-11-27 06:00:00
- End Date: 2024-11-27 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.25 hours
- Commercial Support: Source: Lilly (Any division) - Amount: 62032.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest